Ranitidine 150 mg tablets, 24 count bottles, NDC 37808-196-01.
Published January 15, 2020 · Recall initiated: December 26, 2019
Summary
FDA records drug Class II recall D-0645-2020, published January 15, 2020 and initiated December 26, 2019. Recalling firm: AAA Pharmaceutical, Inc.; Status: Terminated; Reported quantity: 34,272 (24-count bottles); Lot: P134458, Sept 2020 P134943, Aug 2020 P135840, Aug, 2020 P136622, April 2021 P136871, April 2021 P137347, April 2021 P137424, April 2021. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
CGMP Deviations: Impurity N-nitrosodimethylamine (NDMA) found in API
What to do
Voluntary: Firm initiated · Letter
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- AAA Pharmaceutical, Inc.
- Distributor
- Product was distributed to one consignee who may have distributed the product further to their retail stores.
- Lot
- P134458, Sept 2020 P134943, Aug 2020 P135840, Aug, 2020 P136622, April 2021 P136871, April 2021 P137347, April 2021 P137424, April 2021
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDADiscount Drug Mart, Allergy Relief, Fexofenadine Hydrochloride Tablets, 180 mg /Antihistamine, Indoor/OutdoorMarch 11, 2020
- FDARanitidine 150 mg tablets, 130 count bottles, NDC 37808-196-04.January 15, 2020
- FDAGlenmark Ranitidine Tablets USP 150 mg Rx Only 500 Tablets Manufactured by: Glenmark Pharmaceuticals Ltd.January 15, 2020
- FDAGlenmark Ranitidine Tablets USP 300 mg Rx Only 250 Tablets Manufactured by: Glenmark Pharmaceuticals Ltd.January 15, 2020
- FDARanitidine Capsules 300 mg, 30 count bottles. Rx only, Manufactured by: Appco Pharma LLC, Piscataway, NJJanuary 15, 2020
- FDASmart Sense Regular Strength Aspirin Tablets, 325 mg packed in a) 100 count UPC 8-8397-38781-6 and b) 500August 14, 2019
Questions about this recall
Was Ranitidine 150 mg tablets, 24 count bottles, NDC 37808-196-01. recalled?
Yes. FDA published recall D-0645-2020 on January 15, 2020. Reported hazard: CGMP Deviations: Impurity N-nitrosodimethylamine (NDMA) found in API
What should I do if I have this product?
Voluntary: Firm initiated · Letter